子宫内膜癌中双体细胞错配修复基因致病变异与Lynch综合征同样常见
研究纳入341例子宫内膜癌患者,所有肿瘤行错配修复蛋白免疫组化、微卫星不稳定检测及MLH1甲基化检测,对缺乏MLH1甲基化的dMMR病例行胚系基因检测,未发现胚系致病变异者行肿瘤测序。结果显示dMMR病例中Lynch综合征与双体细胞MMR致病变异各占一部分,提示对非甲基化dMMR肿瘤行肿瘤与胚系配对检测可能是Lynch综合征筛查最有效的方式。
要点
- dMMR子宫内膜癌中双体细胞MMR致病变异与Lynch综合征频率相当
- 非甲基化dMMR肿瘤建议行肿瘤与胚系配对检测以筛查Lynch综合征
- 多数dMMR肿瘤由MLH1甲基化解释
核心结论
- 在子宫内膜癌患者中,双体细胞MMR基因致病变异与Lynch综合征同样常见。
- 对非甲基化dMMR肿瘤患者行肿瘤与胚系配对检测可能是Lynch综合征筛查最有效的方式。
研究设计与样本
- 所有肿瘤行四种MMR蛋白免疫组化染色、MSI检测,MMR缺陷肿瘤行MLH1甲基化检测。
- 对缺乏MLH1甲基化的dMMR病例行Lynch综合征胚系基因检测,未发现胚系MMR基因致病变异者行肿瘤测序。
主要发现
- dMMR病例中多数存在MLH1甲基化,为69例,占dMMR病例的75.8%、全部病例的20.2%。
- 22例(6.5%)dMMR不能由甲基化解释,其中10例(全部病例的2.9%)为Lynch综合征(6例MSH6、3例MSH2、1例PMS2)。
- 其余12例dMMR病例(全部病例的3.5%)由双体细胞MMR致病变异所致。
临床怎么用
- 对子宫内膜癌患者可先行肿瘤MMR免疫组化与MSI检测,dMMR者检测MLH1甲基化。
- 对缺乏MLH1甲基化的dMMR肿瘤,可考虑肿瘤与胚系配对检测以同时识别Lynch综合征与双体细胞MMR致病变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lynch syndrome is the most common cause of inherited endometrial cancer, attributable to germline pathogenic variants (PV) in mismatch repair (MMR) genes. Tumor microsatellite instability (MSI-high) and MMR IHC abnormalities are characteristics of Lynch syndrome. Double somatic MMR gene PV also cause MSI-high endometrial cancers. The aim of this study was to determine the relative frequency of Lynch syndrome and double somatic MMR PV. METHODS: 341 endometrial cancer patients enrolled in the Ohio Colorectal Cancer Prevention Initiative at The Ohio State University Comprehensive Cancer Center from 1/1/13-12/31/16. All tumors underwent immunohistochemical (IHC) staining for the four MMR proteins, MSI testing, and MLH1 methylation testing if the tumor was MMR-deficient (dMMR). Germline genetic testing for Lynch syndrome was undertaken for all cases with dMMR tumors lacking MLH1 methylation. Tumor sequencing followed if a germline MMR gene PV was not identified. RESULTS: Twenty-seven percent (91/341) of tumors were either MSI-high or had abnormal IHC indicating dMMR. As expected, most dMMR tumors had MLH1 methylation; (69, 75.8% of the dMMR cases; 20.2% of total). Among the 22 (6.5%) cases with dMMR not explained by methylation, 10 (2.9% of total) were found to have Lynch syndrome (6 MSH6, 3 MSH2, 1 PMS2). Double somatic MMR PV accounted for the remaining 12 dMMR cases (3.5% of total). CONCLUSIONS: Since double somatic MMR gene PV are as common as Lynch syndrome among endometrial cancer patients, paired tumor and germline testing for patients with non-methylated dMMR tumor may be the most efficient approach for LS screening.
引用
- Hampel H, Pearlman R, de la Chapelle A, et al. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecol Oncol. 2020. PMID: 33393477. doi:10.1016/j.ygyno.2020.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。